Association of plasma levels of tumor necrosis factor (TNF)-α and its soluble receptors, two polymorphisms of the TNF gene, with acute severe pancreatitis and early septic shock due to it

Pancreas

Volumn 26, Issue 4, 2003, Pages 339-343

  Dianliang, Zhang ^a,b   Jieshou, Li ^a   Zhiwei, Jiang ^a   Baojun, Yu ^a  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Acute pancreatitis; Polymorphism; Septic shock; Tumor necrosis factor Tumor necrosis factor receptor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPTIC SHOCK;

ACUTE DISEASE; ADULT; AGED; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA; FEMALE; GENE FREQUENCY; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; PANCREATITIS; POLYMORPHISM, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038744599     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200305000-00005     Document Type: Article

References (32)

1. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death. Crit Care Med 1999;27:749-755.
2. Bradley EL. Antibiotics in acute pancreatitis: current status and future directions. Am J Surg 1989;158:472-477.
3. Schmid SW, Uhl W, Friess H, et al. The role of infection in acute pancreatitis. Gut 1999;45:311.
4. Grewal HP, Kotb M, el Din AM, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994;115:213-221.
5. Van der Poll T, Jansen J, Van Leenen D, et al. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis 1993;168:955-996.
6. Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-560.
7. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-α by mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-231.
8. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor α promotor polymorphism effects transcription. Mol Immunol 1997;34:391-399.
9. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
10. Brinkman BM, Zuijdeest D, Kaijzel EL, et al. Relevance of the tumor necrosis factor alpha (TNF-α)-308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1996;46:32-41.
11. McGuire W, Hill AV, Allsopp CE, et al. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-510.
12. Cabrera M, Shaw MA, Sharples C, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995;182:1259-1264.
13. Nadel S, Newport MJ, Booy R, et al. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174:878-880.
14. Mira JP, Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 1999 11;282:561-568.
15. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an Ncol polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-β production. J Exp Med 1991;173:209-219.
16. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-384.
17. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al. Evaluation of the clinical usefulness of APACHEII and SAPS systems in initial prognostic classification of acute pancreatitis: a multiple study. Pancreas 1993;8:682-686.
18. Balthazar EJ, Robinson DL, Megibow AJ, et al. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336.
19. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definition of sepsis and organ failure and guideline for the use of innovative therapies in sepsis. Crit Care Med 1997;25:953-957.
20. Wilson AG, di Giovine FS, Blakemore AI, et al. Single base polymorphism in the human tumor necrosis factor alpha (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
21. Powell JJ, Fearon KCH, Siriwardena AK, et al. Evidence against a role polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001;129:633-640.
22. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP 2000;1:24-35.
23. de Beaux AC, Goldie AS, Ross JA, et al. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996;83:349-353.
24. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: an early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis. Crit Care Med 1999;27:749-755.
25. Kaufmann P, Tilz GP, Lueger A, et al. Elevated plasma levels of soluble tumor necrosis receptor (sTNFp60) reflect severity of acute pancreatitis. Intensive Care Med 1997;23:841-848.
26. Aderka D, Engelmann H, Maor Y, et al. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323-329.
27. Majetschak M, Flohe S, Obertacke U, et al. Relation of TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 1999;230:207-214.
28. Stüber F, Udalova IA, Book M, et al. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human promotor. J Inflamm 1996;46:42-50.
29. Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998;52:359-367.
30. van der Poll T, Sauerwein HP. Tumor necrosis factor-alpha: its role in the metabolic response to sepsis. Clin Sci 1993;84:247-256.
31. Tracey KJ, Lowry SF. The role of cytokine mediators in septic shock. Adv Surg. 1990;23:21-56.
32. Dominguez-Munoz JE, Carballo F, Garcia MJ, et al. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: results of a multicenter study. Br J Surg 1991;78:1230-1234.